{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T20:43:53Z","timestamp":1788468233753,"version":"build-2803163510"},"reference-count":24,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2015,4,1]],"date-time":"2015-04-01T00:00:00Z","timestamp":1427846400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["cancerepidemiology.net","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cancer Epidemiology"],"published-print":{"date-parts":[[2015,4]]},"DOI":"10.1016\/j.canep.2015.01.014","type":"journal-article","created":{"date-parts":[[2015,2,23]],"date-time":"2015-02-23T09:37:35Z","timestamp":1424684255000},"page":"242-249","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":24,"title":["Risk of Wernicke's encephalopathy and cardiac disorders in patients with myeloproliferative neoplasm"],"prefix":"10.1016","volume":"39","author":[{"given":"Jasmanda","family":"Wu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ling","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anjali","family":"Vaze","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juhaeri","family":"Juhaeri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.canep.2015.01.014_bib0125","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1182\/blood-2009-03-209262","article-title":"The 2008 revision of the World Health Organization (WHO) classification of myeloid neoplasms and acute leukemia: rationale and important changes","volume":"114","author":"Vardiman","year":"2009","journal-title":"Blood"},{"key":"10.1016\/j.canep.2015.01.014_bib0130","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1200\/JCO.2010.29.8711","article-title":"Myeloproliferative neoplasms: molecular pathophysiology, essential clinical understanding, and treatment strategies","volume":"29","author":"Tefferi","year":"2011","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.canep.2015.01.014_bib0135","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1016\/S0369-8114(00)00023-7","article-title":"Epidemiology of the myeloproliferative disorders: essential thrombocythaemia, polycythaemia vera and idiopathic myelofibrosis","volume":"49","author":"Kutti","year":"2001","journal-title":"Pathol Biol"},{"key":"10.1016\/j.canep.2015.01.014_bib0140","first-page":"1","article-title":"Management of polycythemia vera and essential thrombocythemia","volume":"20","author":"Campbell","year":"2005","journal-title":"Hematology (Am Soc Hematol Educ Program)"},{"key":"10.1016\/j.canep.2015.01.014_bib0145","doi-asserted-by":"crossref","first-page":"2099","DOI":"10.1002\/cncr.22233","article-title":"Acute myeloid leukemia: epidemiology and etiology","volume":"107","author":"Deschler","year":"2006","journal-title":"Cancer"},{"key":"10.1016\/j.canep.2015.01.014_bib0150","first-page":"1400","article-title":"The incidence and outcome of myeloid malignancies in 2,112 adult patients in southeast England","volume":"91","author":"Phekoo","year":"2006","journal-title":"Haematologica"},{"key":"10.1016\/j.canep.2015.01.014_bib0155","doi-asserted-by":"crossref","first-page":"1684","DOI":"10.1038\/bjc.2011.450","article-title":"Incidence of haematological malignancy by sub-type: a report from the haematological malignancy research network","volume":"105","author":"Smith","year":"2011","journal-title":"Br J Cancer"},{"issue":"10","key":"10.1016\/j.canep.2015.01.014_bib0160","doi-asserted-by":"crossref","first-page":"2083","DOI":"10.1002\/cncr.22630","article-title":"Validation and comparison of contemporary prognostic models in primary myelofibrosis: analysis based on 334 patients from a single institution","volume":"109","author":"Tefferi","year":"2007","journal-title":"Cancer"},{"key":"10.1016\/j.canep.2015.01.014_bib0165","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1182\/blood-2009-08-238956","article-title":"Thrombosis in primary myelofibrosis: incidence and risk factors","volume":"115","author":"Barbui","year":"2010","journal-title":"Blood"},{"key":"10.1016\/j.canep.2015.01.014_bib0170","doi-asserted-by":"crossref","first-page":"1645","DOI":"10.3324\/haematol.13346","article-title":"Prognositic factors for thrombosis, myelofibrosis, and leukemia in essential thrombocythemia: a study of 605 patients","volume":"93","author":"Passamonti","year":"2008","journal-title":"Haematologica"},{"key":"10.1016\/j.canep.2015.01.014_bib0175","doi-asserted-by":"crossref","first-page":"3135","DOI":"10.1182\/blood-2008-04-153783","article-title":"Thrombocytosis and leukocytosis interaction in vascular complications of essential thrombocythemia","volume":"112","author":"Carobbio","year":"2008","journal-title":"Blood"},{"key":"10.1016\/j.canep.2015.01.014_bib0180","doi-asserted-by":"crossref","first-page":"2224","DOI":"10.1200\/JCO.2005.07.062","article-title":"Vascular and neoplastic risk in a large cohort patients with polychthemia vera","volume":"23","author":"Marchioli","year":"2005","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.canep.2015.01.014_bib0185","doi-asserted-by":"crossref","first-page":"2391","DOI":"10.1056\/NEJMoa1312542","article-title":"Somatic CALR mutations in myeloproliferative neoplasms with nonmutated JAK2","volume":"369","author":"Nangalia","year":"2013","journal-title":"New Engl J Med"},{"key":"10.1016\/j.canep.2015.01.014_bib0190","doi-asserted-by":"crossref","first-page":"1552","DOI":"10.1182\/blood-2013-11-538983","article-title":"Impact of calreticulin mutations on clinical and hematological phenotype and outcome in essential thrombocythemia","volume":"123","author":"Rotunno","year":"2014","journal-title":"Blood"},{"key":"10.1016\/j.canep.2015.01.014_bib0195","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1016\/S1474-4422(07)70104-7","article-title":"Wernicke's encephalopathy: new clinical settings and recent advances in diagnosis and management","volume":"6","author":"GianPietro","year":"2007","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.canep.2015.01.014_bib0200","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1159\/000174951","article-title":"Wernicke's encephalopathy: an underrecognized and reversible cause of confusional state in cancer patients","volume":"76","author":"Kuo","year":"2009","journal-title":"Oncology"},{"issue":"Suppl. VII","key":"10.1016\/j.canep.2015.01.014_bib0205","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1007\/978-3-642-81553-9_101","article-title":"Prospective neuropathologic study on the occurrence of Wernicke's encephalopathy in patients with tumors of the lymphoid-hemopoietic systems","author":"De Reuck","year":"1981","journal-title":"Acta Neuropathol"},{"key":"10.1016\/j.canep.2015.01.014_bib0210","unstructured":"Health Insurance Portability and Accountability Act of 1996. 42 USC 1320-d2."},{"issue":"2","key":"10.1016\/j.canep.2015.01.014_bib0215","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1079\/PHN19980018","article-title":"Wernicke\u2013Korsakoff syndrome in Sydney hospitals after 6 years of thiamin enrichment of bread","volume":"1","author":"Rolland","year":"1998","journal-title":"Public Health Nutr"},{"key":"10.1016\/j.canep.2015.01.014_bib0220","unstructured":"Mini-Sentinel systematic evaluation of health outcome of interest definitions for studies using administrative data \u2013 congestive heart failure. http:\/\/www.mini-sentinel.org\/work_products\/HealthOutcomes\/MS_HOI_CHFReport.pdf. Accessed 14.04.14."},{"key":"10.1016\/j.canep.2015.01.014_bib0225","unstructured":"Mini-Sentinel systematic validation of health outcome of interest \u2013 acute myocardial infarction cases report. http:\/\/www.mini-sentinel.org\/work_products\/Validation_HealthOutcomes\/Mini-Sentinel-Validation-of-AMI-Cases.pdf. Accessed 14.04.14."},{"key":"10.1016\/j.canep.2015.01.014_bib0230","unstructured":"Mini-Sentinel systematic evaluation of health outcome of interest definitions for studies using administrative data \u2013 cardiac arrhythmias report. http:\/\/www.mini-sentinel.org\/work_products\/HealthOutcomes\/MS_HOI_CardiacArrhythmiasReport.pdf. Accessed 14.04.14."},{"key":"10.1016\/j.canep.2015.01.014_bib0235","doi-asserted-by":"crossref","first-page":"1130","DOI":"10.1097\/01.mlr.0000182534.19832.83","article-title":"Coding algorithms for defining comorbidities in ICD-9-CM and ICD-10 administrative data","volume":"43","author":"Quan","year":"2005","journal-title":"Med Care"},{"key":"10.1016\/j.canep.2015.01.014_bib0240","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1016\/0895-4356(92)90133-8","article-title":"Adapting a clinical comorbidity index for use with ICD-9-CM administrative databases","volume":"45","author":"Deyo","year":"1992","journal-title":"J Clin Epidemiol"}],"container-title":["Cancer Epidemiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S187778211500034X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S187778211500034X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,24]],"date-time":"2018-09-24T19:52:37Z","timestamp":1537818757000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S187778211500034X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,4]]},"references-count":24,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2015,4]]}},"alternative-id":["S187778211500034X"],"URL":"https:\/\/doi.org\/10.1016\/j.canep.2015.01.014","relation":{},"ISSN":["1877-7821"],"issn-type":[{"value":"1877-7821","type":"print"}],"subject":[],"published":{"date-parts":[[2015,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Risk of Wernicke's encephalopathy and cardiac disorders in patients with myeloproliferative neoplasm","name":"articletitle","label":"Article Title"},{"value":"Cancer Epidemiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.canep.2015.01.014","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}